Effects of Cognitive Training on Children With Attention Deficit Hyperactivity Disorder

August 13, 2018 updated by: Ru-Lan Hsieh, Taipei Medical University

Treatment Effects of Cognitive Training on Children With Attention Deficit Hyperactivity Disorder and Developmental Delay

Using a single blind, randomized controlled design to study the additional therapeutic effects of cognitive training on traditional rehabilitation programs for children with attention deficit hyperactivity disorder and developmental delays.

Study Overview

Detailed Description

A total of 30 children with attention deficit hyperactivity disorder and developmental delays who are receiving traditional rehabilitation programs will be enrolled.

The participants will be randomized into two groups, including study group (traditional rehabilitation program with additional cognitive training: 2 times per week, 15 min per session, a total of 24 sessions) and control group (traditional rehabilitation program without additional cognitive training).

Memory related functions, quality of life, and physical function evaluations will be performed at baseline, 3 months and 6 months later, respectively.

Evaluator will be blinded to the group's classification during the whole course of study.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Taipei, Taiwan, 111-01
        • Shin Kong Wu Ho-Su Memorial Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 8 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children diagnosed with attention deficit hyperactivity disorder with developmental delay receiving regular rehabilitation programs intelligence quotient 70 or greater

Exclusion Criteria:

  • age less than 4 years or elder than 8 years children diagnosed with attention deficit hyperactivity disorder receiving regular rehabilitation programs intelligence quotient less than 70

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: study group
3 months of individualized interactive cognitive training, 2 times per week, 15 min per session, a total of 24 sessions, in addition to traditional rehabilitation programs.
Using interactive brain club system training to children with attention deficit hyperactivity disorder with developmental delay
No Intervention: control group
3 months of traditional rehabilitation programs, without individualized interactive cognitive training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of attention
Time Frame: scores change from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Swanson, Nolan and Pelham questionnaire
scores change from baseline to 3 months of treatment, and 3 months after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of visual motor integration
Time Frame: scores change from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Beery-Buktenica Visual Motor Integration Test
scores change from baseline to 3 months of treatment, and 3 months after treatment
change of sensory integration
Time Frame: scores change from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Sensory Profile questionnaire
scores change from baseline to 3 months of treatment, and 3 months after treatment
change of intelligence
Time Frame: scores change from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Wechsler Intelligence Scale for Children, including verbal, performance and total scores, the average score is 100, with higher scores indicating higher than average intelligence and lower scores indicating lower levels of intelligence
scores change from baseline to 3 months of treatment, and 3 months after treatment
change of functional performance
Time Frame: changes from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Pediatric Outcome Data Collection Instrument
changes from baseline to 3 months of treatment, and 3 months after treatment
change of health-related quality of life
Time Frame: changes from baseline to 3 months of treatment, and 3 months after treatment
score assessed by Pediatric Quality of Life Inventory-Generic Core Scales, including physical, psychosocial, and total scores, with higher scores representing better health-related quality of life
changes from baseline to 3 months of treatment, and 3 months after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2018

Primary Completion (Anticipated)

March 1, 2019

Study Completion (Anticipated)

March 1, 2019

Study Registration Dates

First Submitted

July 13, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 15, 2018

Study Record Updates

Last Update Posted (Actual)

August 15, 2018

Last Update Submitted That Met QC Criteria

August 13, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Hyperactivity Disorder

Clinical Trials on interactive cognitive training

3
Subscribe